Status:
COMPLETED
Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer
Lead Sponsor:
Yangzhou University
Conditions:
Heparin
Perioperative
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Heparin diluent or normal saline is generally used as the arterial tube flushing in clinical practice, but there is no consensus on the choice of flushing fluid. Heparin can affect the blood coagulati...
Eligibility Criteria
Inclusion
- Diagnosis of gastrointestinal cancer
- Ages ranged from 18 to 75
- ASA I\~III
Exclusion
- Pregnancy
- modified Allen Test negative
- history of taking anti-platelet drugs such as aspirin one week before surgery, heparin allergy and thrombotherapy
- two failed catheterizations of the same artery
- significant diseases in liver and kidney function
- refusal of patients
Key Trial Info
Start Date :
January 24 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04355273
Start Date
January 24 2018
End Date
December 1 2019
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Affiliated Hospital of Yangzhou University, Yangzhou University
Yangzhou, Jiangsu, China, 225012